• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur J Clin Invest . Interferon lambda 3 in the early phase of coronavirus disease-19 can predict oxygen requirement

tetano

Editor, Senior Moderator
Eur J Clin Invest


. 2022 May 4;e13808.
doi: 10.1111/eci.13808. Online ahead of print.
Interferon lambda 3 in the early phase of coronavirus disease-19 can predict oxygen requirement


Tetsuya Suzuki[SUP] 1 2 [/SUP], Noriko Iwamoto[SUP] 1 2 [/SUP], Shinya Tsuzuki[SUP] 1 3 [/SUP], Yuko Kakumoto[SUP] 1 [/SUP], Michiyo Suzuki[SUP] 1 [/SUP], Shinobu Ashida[SUP] 1 [/SUP], Yusuke Oshiro[SUP] 4 [/SUP], Takeshi Nemoto[SUP] 4 [/SUP], Kohei Kanda[SUP] 1 [/SUP], Ayako Okuhama[SUP] 1 [/SUP], Gen Yamada[SUP] 1 [/SUP], Makoto Inada[SUP] 1 [/SUP], Lubna Sato[SUP] 1 [/SUP], Yusuke Miyazato[SUP] 1 [/SUP], Yutaro Akiyama[SUP] 1 [/SUP], Sho Saito[SUP] 1 2 [/SUP], Shinichiro Morioka[SUP] 1 2 [/SUP], Mugen Ujiie[SUP] 1 [/SUP], Kayoko Hayakawa[SUP] 1 [/SUP], Masaya Sugiyama[SUP] 5 [/SUP], Masashi Mizokami[SUP] 5 [/SUP], Eiichi N Kodama[SUP] 6 [/SUP], Norio Ohmagari[SUP] 1 2 [/SUP]



Affiliations

No abstract availableKeywords: COVID-19; Interferon lambda 3; markers for disease progression; supplemental oxygen.
 
Back
Top Bottom